News
Investor's Business Daily on MSN48m
Kenvue Yo-Yoes After Tylenol-Maker Unveils New CEO, Strategic ReviewKenvueKVUE stock yo-yoed Monday after the down-and-out health care player — known for brands like Aveeno, Band-Aid and ...
Investor's Business Daily on MSN48m
Ultragenyx Pharma Takes Another Hit As FDA Slaps Its Gene Therapy With A RejectionUltragenyx Pharmaceuticals took another hit when the FDA rejected its gene therapy for patients with a rare, genetic disorder.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback